AUPH FY 2011 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$927,522-72.9% YoY

Gross Profit

$742,41080.0% margin

Operating Income

-$6M-694.2% margin

Net Income

-$2M-259.6% margin

EPS (Diluted)

$-0.70

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$3M

Stock-Based Comp.

$371,204

Balance Sheet

Total Assets

$14M

Total Liabilities

$8M

Stockholders' Equity

$6M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$927,522	$3M	-72.9%
Gross Profit	$742,410	$3M	-78.0%
Operating Income	-$6M	-$5M	-27.6%
Net Income	-$2M	-$4M	+34.2%